Chargement en cours...
Regulatory post‐market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies
Information on rare adverse effects is often limited when a medication is initially approved for marketing. Medicines regulators use safety advisories to warn health professionals and consumers about emerging harms. This study aimed to identify characteristics and advice provided in cardiac safety a...
Enregistré dans:
| Publié dans: | Pharmacol Res Perspect |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7652786/ https://ncbi.nlm.nih.gov/pubmed/33169534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.680 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|